A Study In Patients With Non-Small Cell Lung Cancer To Test If Erlotinib Plus SU011248 Is Better Than Erlotinib Alone

Clinical trial NCT00457392 · COMPLETED

Trial details

NCT number: NCT00457392
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Non-Small Cell Lung

Start date: 2007-07-01
Primary completion: 2010-07-01
Enrollment: 960

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.